Literature DB >> 25683267

Evidence of meaningful levels of Trypanosoma cruzi in platelet concentrates from seropositive blood donors.

Beatriz Cancino-Faure1, Roser Fisa1, Cristina Riera1, Ibeth Bula1, Enrique Girona-Llobera2,3, Teresa Jimenez-Marco2,3.   

Abstract

BACKGROUND: According to the reported cases of transfusion-acquired Trypanosoma cruzi infection, the risk of T. cruzi transfusion transmission appears to be higher with platelet (PLT) products than with other blood components. The aim of this study was to investigate by quantitative real-time polymerase chain reaction (qPCR) the parasitic load detected in leukoreduced plasma and PLT concentrates collected by apheresis from seropositive T. cruzi blood donors and compare them with peripheral whole blood (WB). STUDY DESIGN AND METHODS: During 2011 to 2013, a prospective study was carried out in a group of blood donors originating from Chagas-endemic areas but who are now living on the island of Majorca, Spain. Leukoreduced plasma and PLT concentrates were collected by apheresis from seropositive blood donors with detectable parasitemias in peripheral WB.
RESULTS: Seropositivity was found in 23 of 1201 donors studied (1.9%), and T. cruzi DNA with less than 1 parasite equivalent/mL was detected in peripheral WB in 60.86% (14 of 23) of these. The study in blood components obtained by apheresis from these donors showed that T. cruzi DNA with a mean ± SD parasitic load of 5.33 ± 6.12 parasite equivalents/mL was detected in 100% of the PLT concentrate samples. Parasite DNA was undetectable in the extract taken from plasma collected from donors with a positive qPCR in peripheral WB.
CONCLUSION: The higher parasitic load found in PLT concentrates compared to plasma and peripheral WB would explain the higher transfusion transmission risk of Chagas disease associated with PLT transfusions described in the reported cases of transfusion-acquired T. cruzi infection.
© 2015 AABB.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25683267     DOI: 10.1111/trf.12989

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  9 in total

1.  Why are platelets the most frequently mentioned blood component in Chagas transfusion transmission reports?

Authors:  Beatriz Cancino-Faure; Roser Fisa; Cristina Riera; Ibeth Bula; Enrique Girona-Llobera; Teresa Jimenez-Marco
Journal:  Blood Transfus       Date:  2016-03-21       Impact factor: 3.443

2.  Haemostatic function measured by thromboelastography and metabolic activity of platelets treated with riboflavin and UV light.

Authors:  Carme Ballester-Servera; Teresa Jimenez-Marco; Daniel Morell-Garcia; Miguel Quetglas-Oliver; Antonia M Bautista-Gili; Enrique Girona-Llobera
Journal:  Blood Transfus       Date:  2020-05-15       Impact factor: 3.443

Review 3.  Chronic Chagas Disease-the Potential Role of Reinfections in Cardiomyopathy Pathogenesis.

Authors:  Christian Olivo Freites; Hendrik Sy; Amal Gharamti; Nelson I Agudelo Higuita; Carlos Franco-Paredes; José Antonio Suárez; Andrés F Henao-Martínez
Journal:  Curr Heart Fail Rep       Date:  2022-08-11

4.  Automatic detection of the parasite Trypanosoma cruzi in blood smears using a machine learning approach applied to mobile phone images.

Authors:  Mauro César Cafundó Morais; Diogo Silva; Matheus Marques Milagre; Maykon Tavares de Oliveira; Thaís Pereira; João Santana Silva; Luciano da F Costa; Paola Minoprio; Roberto Marcondes Cesar Junior; Ricardo Gazzinelli; Marta de Lana; Helder I Nakaya
Journal:  PeerJ       Date:  2022-05-27       Impact factor: 3.061

5.  Chronic Chagas Disease Diagnosis: A Comparative Performance of Commercial Enzyme Immunoassay Tests.

Authors:  Fred Luciano Neves Santos; Wayner Vieira de Souza; Michelle da Silva Barros; Mineo Nakazawa; Marco Aurélio Krieger; Yara de Miranda Gomes
Journal:  Am J Trop Med Hyg       Date:  2016-03-14       Impact factor: 2.345

6.  Detection and Quantification of Viable and Nonviable Trypanosoma cruzi Parasites by a Propidium Monoazide Real-Time Polymerase Chain Reaction Assay.

Authors:  Beatriz Cancino-Faure; Roser Fisa; M Magdalena Alcover; Teresa Jimenez-Marco; Cristina Riera
Journal:  Am J Trop Med Hyg       Date:  2016-05-02       Impact factor: 2.345

7.  First Documented Transmission of Trypanosoma cruzi Infection through Blood Transfusion in a Child with Sickle-Cell Disease in Belgium.

Authors:  Sophie Blumental; Micheline Lambermont; Catherine Heijmans; Marie-Pierre Rodenbach; Hanane El Kenz; Danièle Sondag; Emmanuel Bottieau; Carine Truyens
Journal:  PLoS Negl Trop Dis       Date:  2015-10-15

8.  Screening for Trypanosoma cruzi infection in immigrants and refugees: Systematic review and recommendations from the Spanish Society of Infectious Diseases and Clinical Microbiology.

Authors:  María Velasco; Luis Andrés Gimeno-Feliú; Israel Molina; Joaquín Salas-Coronas; Ivan Solà; Begoña Monge-Maillo; Diego Torrús-Tendero; Joan Caylà; Ena Niño de Guzmán; Jl Pérez Arellano; Jose A Pérez-Molina
Journal:  Euro Surveill       Date:  2020-02

9.  Risk Factors and Screening for Trypanosoma cruzi Infection of Dutch Blood Donors.

Authors:  Ed Slot; Boris M Hogema; Michel Molier; Aldert Bart; Hans L Zaaijer
Journal:  PLoS One       Date:  2016-03-07       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.